US regulatory status: approved. Molecular target: Estrogen receptor.
- Target
- Estrogen receptor
- Mechanism
- Estrogen receptor alpha agonist
pharma · Neurogenic Detrusor Overactivity
Astellas Pharma
Astellas Pharma Europe B. V.
Astellas Pharma drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
JP HQ
12,378 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- JP
- Employees
- 12,378
- Programs
- 1
- Drugs
- 2
- Patents
- 10
Astellas Pharma pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Astellas Pharma drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Molecular target: Muscarinic acetylcholine receptor M2.
- Target
- Muscarinic acetylcholine receptor M2
- Mechanism
- Muscarinic acetylcholine receptor M3 antagonist